35
Allotera Therapeutics, Inc. files Form D
Company raise update · Raising · Offering $163M · Sold $123.3M · ST. LOUIS, MO · filed 2026-07-23
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Natalie Mount | Director |
| Ayman Kabakibi | Executive Officer |
| Drew Dennison | Director |
| Niall O'Donnell | Director |
| Bali Muralidhar | Director |
| Bosun Hau | Director |
| Kevin Li | Director |
| Peter Kiener | Director |
| Matthew Cooper | Executive Officer |
| Cherry Thomas | Executive Officer |
| Kumar Srinivasan | Executive Officer, Director |
| Keith Vendola | Executive Officer |
Signed by Kumar Srinivasan, President and Chief Executive Officer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.